Westrock Company Common Stock When Issued (WRKW) Quote

https://x.com/jmoney_hoops/status/1813468075217576273?s=46&t=EuLw-SVIgNfV5yGP5vc4tQ

Geesh. The Mfer even lied about the bullet/glass

https://x.com/OneMargaux/status/1813437182524404043?s=19

I truly believe BC will not be needed, other than a backup. In my opinion Bishop and Inyo county Will lite up like a Christmas tree for Jared and company.

It is, isn't it?

Not at Liberty to discuss Just be careful Same ol Henry Nothing changes with him

What?

Talking to these people is utterly exhausting.

$RSLS >>> Don't miss this NASDAQ/US biotech gem! Merger!!! Primed. DYOR.

$RSLS ~ ReShape Lifesciences Inc
@0.2394 +0.0117 (+5.14%)
Volume: 987,303
Day Range: 0.214 - 0.2393(!)
Last Trade Time: 7:53:46 PM EDT
https://ih.advfn.com/p.php?pid=staticchart

$RSLS >>> Don't miss this NASDAQ/US biotech gem! Merger!!! Primed. DYOR.

$RSLS ~ ReShape Lifesciences Inc
@0.2394 +0.0117 (+5.14%)
Volume: 987,303
Day Range: 0.214 - 0.2393(!)
Last Trade Time: 7:53:46 PM EDT
https://ih.advfn.com/p.php?pid=staticchart

TKLF:Earning per share 20 cents share price 58 cents. Grossly undervalued....

Fiscal Year 2024 Financial Highlights

Total revenue was $195.7 million for fiscal year 2024, increased by 15.3% from $169.7 million for fiscal year 2023.

Income from operations

$RSLS ~ ReShape Lifesciences Inc
@0.2394 +0.0117 (+5.14%)
Volume: 987,303
Day Range: 0.214 - 0.2393(!)
Last Trade Time: 7:53:46 PM EDT
https://ih.advfn.com/p.php?pid=staticchart&s=NASDAQ%3ARSLS&p=0&t=17&width=288&height=147&vol=1&delay=1&min_pre=330&min_after=240

Cover! Imo

$RSLS ~ ReShape Lifesciences Inc
@0.2394 +0.0117 (+5.14%)
Volume: 987,303
Day Range: 0.214 - 0.2393(!)
Last Trade Time: 7:53:46 PM EDT
https://ih.advfn.com/p.php?pid=staticchart&s=NASDAQ%3ARSLS&p=0&t=17&width=288&height=147&vol=1&delay=1&min_pre=330&min_after=240

TKLF, $196 Million Rev, $7.5 Million Net Profit, 42 million Outstanding shares.. Earning per share 20 cents share price 58 cents.lt is grossly undervalued....

Fiscal Year 2024 Financial Highlights

Total revenue was $195.7 million for fiscal year 2024, increased by 15.3%

TKLF: Earning per share 20 cents share price 58 cents.lt is grossly undervalued....

Fiscal Year 2024 Financial Highlights

Total revenue was $195.7 million for fiscal year 2024, increased by 15.3% from $169.7 million for fiscal year 2023.

Income from oper

TKLF, $196 Million Rev, $7.5 Million Net Profit, 42 million Outstanding shares.. Earning per share 20 cents share price 58 cents. lt is grossly undervalued....

Fiscal Year 2024 Financial Highlights

Total revenue was $195.7 million for fiscal year 2024, increased by 15.3

Yes should be the case

We're so screwed!

And to have turned his head at just the right moment.

RIPPLE XRP 2PAC HAIL MARY $3 TARGET yo guys don’t miss this one

Leave it to lucky duck Trump to draw the most incompetent assassin in the history of assassins. 👿

LOLOLOL!!

Great, I love reading technical documents written for/by shady OTC companies. I look forward to seeing how they explain the 8% iridium, the native iron, the PGMs, and what the REE concentrations actually are. And hopefully their math skills are better than Dan's.

Maybe you can help

hope its soon..................